Literature DB >> 10798804

Modified uniform seed loading for prostate brachytherapy: rationale, design, and evaluation.

G S Merrick1, W M Butler.   

Abstract

PURPOSE: Despite a multitude of preplanning approaches and seed loading philosophies, multiple groups have reported comparable results in terms of biochemical disease-free survival and complication rates. None of the seed loading philosophies have been proven superior and no generally accepted loading philosophy has been adopted by the brachytherapy community.
MATERIALS AND METHODS: Review of the preplanning philosophy, preplanning dosimetry, and preimplant evaluation is presented.
RESULTS: A modified uniform seed loading approach is used because of its ability to deliver a relatively homogeneic dose to the prostate gland with a periprostatic margin, to routinely maintain the urethral dose at approximately 115% of the prescribed dose and to avoid significant rectal and urinary toxicity.
CONCLUSION: Of the commonly utilized seed loading philosophies, a modified uniform approach delivers a relatively homogeneic dose to the prostate gland/periprostatic region and is the most forgiving of local and systematic errors in seed placement.

Entities:  

Mesh:

Year:  2000        PMID: 10798804

Source DB:  PubMed          Journal:  Tech Urol        ISSN: 1079-3259


  7 in total

Review 1.  A review on permanent implants for prostate brachytherapy with comparison between stranded and loose seeds.

Authors:  Guangchao Wei; Ping Jiang; Chunxiao Li; Shuhua Wei; Yuliang Jiang; Haitao Sun; Junjie Wang
Journal:  Jpn J Radiol       Date:  2021-09-04       Impact factor: 2.374

2.  Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSA.

Authors:  Gregory S Merrick; Robert W Galbreath; Wayne M Butler; Ryan Fiano; Edward Adamovich
Journal:  J Contemp Brachytherapy       Date:  2017-08-30

3.  Biological effective dose in analysis of rectal dose in prostate cancer patients who underwent a combination therapy of VMAT and LDR with hydrogel spacer insertion.

Authors:  Honglai Zhang; Lin Wang; Adam C Riegel; Jeffrey Antone; Louis Potters; Lucille Lee; Yijian Cao
Journal:  J Appl Clin Med Phys       Date:  2022-03-14       Impact factor: 2.243

4.  Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatment.

Authors:  Al V Taira; Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Ryan Fiano; Kent E Wallner; Edward Adamovich
Journal:  J Contemp Brachytherapy       Date:  2013-12-03

5.  Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts.

Authors:  Gregory S Merrick; Wayne M Butler; Robert W Galbreath; Ryan Fiano; Edward Adamovich
Journal:  J Contemp Brachytherapy       Date:  2015-12-30

6.  Dosimetry advantages of intraoperatively built custom-linked seeds compared with loose seeds in permanent prostate brachytherapy.

Authors:  Masahiro Inada; Masaki Yokokawa; Takafumi Minami; Kiyoshi Nakamatsu; Yasumasa Nishimura
Journal:  J Contemp Brachytherapy       Date:  2017-10-19

7.  Does supplemental external beam radiation therapy impact urinary, bowel, and erectile function following permanent prostate brachytherapy?: results of two prospective randomized trials.

Authors:  Gregory S Merrick; Ava Tennant; Kent E Wallner; Robert Galbreath; Wayne M Butler; Ryan Fiano; Edward Adamovich
Journal:  J Contemp Brachytherapy       Date:  2017-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.